Razan Mohty/X
Mar 4, 2025, 04:35
Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians
Razan Mohty, Assistant Professor at UAB Medicine, shared a paper she and her colleagues authored on X:
“Happy to share our recent manuscript on outcomes of anti-CD19 CART for lymphoma in octogenarians (80 years of age or older).
– CR rate 71.4%
– 1-year OS 61.2%
– 1-year PFS 47.6%
– 1-year NRM 11.6%
Thanks to all collaborators.”
Authors: Mohamed A. Kharfan-Dabaja, Razan Mohty et al.
Aaron P. Rapoport
Amer Beitinjaneh
Amitkumar Mehta
Arushi Khurana
Bhagirathbhai Dholaria
cancer
Deepa Jagadeesh
Ernesto Ayala
Forat Lutfi
Frederick L. Locke
Javier Munoz
Jean Yared
Jennifer Logue
Jose Sandoval-Sus
Joseph McGuirk
Joshua Fein
Julio C. Chavez
Kaitlin Annunzio
Lazaros Lekakis
Madiha Iqbal
Mayur Narkhede
Mehdi Hamadani
Michael D. Jain
Mohamed A. Kharfan-Dabaja
Muhamad Alhaj-Moustafa
Narendranath Epperla
Nausheen Ahmed
Neela Easwar
Olalekan O. Oluwole
OncoDaily
Oncology
Othman Salim Akhtar
Patrick Johnston
Praveen Ramakrishnan Geethakumari
Razan Mohty
Samuel Yamshon
Tsiporah Shore
Urshila Durani
Usama Gergis
Yi Lin
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 23, 2025, 06:49
Apr 23, 2025, 06:34
Apr 23, 2025, 06:24
Apr 23, 2025, 01:36
Apr 22, 2025, 19:24
Apr 22, 2025, 18:28